Biotech Stocks Follow Genentech, OSI Down
691847
Biotechnology stocks moved lower Friday as Genentech Inc. and OSI Pharmaceuticals lost value despite an earlier-than-expected approval of their lung cancer drug Tarceva.
560123
US stocks fell on Friday dragged down by a string of negative reports from drug makers, with Pfizer Inc. (PFE.N: Quote, Profile, Research) , AstraZeneca Plc.
591006
Stocks fell on Wednesday after bank  JPMorgan Chase & Co.JPM.N and drug maker Pfizer Inc. PFE.N  reported disappointing earnings, while a lackluster outlook  from cell-phone maker Motorola Inc. MOT.N stoked concerns  about weak technology spending.
567554
World&#39;s No.2 biotech company beats Wall Street consensus and raises its full-year profit forecast. NEW YORK  - Genentech Inc.
438480
Credit Suisse First Boston said that an announcement from Onyx Pharmaceuticals (nasdaq: ONXX - news - people ) is &quot;good news&quot; for Genentech (nyse: DNA - news - people ) and its Avastin treatment.
759178
The blue-chip Dow average declined  slightly, while the Nasdaq and the S&P 500 were little changed  on Tuesday as investors waited for an expected quarter-point  hike in U.S. interest rates and results from technology  bellwether Cisco Systems Inc. CSCO.O.
263599
U.S. technology shares fell and blue-chip stocks pared gains on Thursday, with shares of BlackBerry maker Research In Motion Ltd.  down after brokerage downgrades of the stock.
44693
Celera Genomics Group of Rockville announced an agreement Tuesday to provide potential targets for cancer drugs to biotech giant Genentech Inc. -The Washington Post
766626
US stocks declined this week as disappointing sales forecasts from technology companies such as Xilinx Inc., Altera Corp. and Texas Instruments Inc.
97511
NEW YORK - A brokerage downgrade of several semiconductor companies pressured tech shares Thursday, but the broader market hovered near unchanged levels as a jump in jobless claims offset investors' relief over declining oil prices.    Late summer trading is known for being thin, but with the Republican National Convention set for New York next week, Wall Street is even less crowded than usual for the last week of August...
406135
US stock futures pointed to a slightly lower open on Tuesday as investors take a step back after last week&#39;s three-day rally, with shares of drug maker Merck &amp; Co.
682567
Merrill Lynch downgraded Chiron (nasdaq: CHIR - news - people ) to &quot;sell&quot; from &quot;neutral&quot; after news reports indicated a flu vaccine from GlaxoSmithKline (nyse: GSK - news - people ) could be approved by the US Food and Drug Administration as early as
262304
Shares of Genentech Inc. DNA.N, OSI  Pharmaceuticals Inc. OSIP.O and ImClone Systems Inc. IMCL.O  surged before the bell on Friday after rival AstraZeneca Plc  AZN.L said its lung cancer drug Iressa failed to show  survival benefits in a major clinical study.
631379
Stocks fell on Thursday as a drop in Eli Lilly and Co  shares and caution before new home sales data offset optimism about earnings from tech companies Motorola Inc  and EMC Corp .
66960
Genentech Inc. barely scraped past Wall Street's expectations Monday as the biotech giant renowned for its phenomenal growth posted a 6 percent rise in fourth-quarter profits.
581460
Genentech announces positive second-quarter results, but investors remain worried.
372947
Stocks of branded and generic drug makers closed down a bit Tuesday as clinical study results mixed with merger updates. One of the big winners on the day was Nektar Therapeutics, on news that Exubera, the